SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-21-013049
Filing Date
2021-05-21
Accepted
2021-05-21 16:37:38
Documents
5
Period of Report
2021-05-21
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A aytu20210520_8ka.htm 8-K/A 25621
2 EXHIBIT 23.1 - CONSENT OF RSM ex_252277.htm EX-23.1 2329
3 EXHIBIT 99.1 - NEOS HISTORICAL FINANCIALS ex_252278.htm EX-99.1 731708
4 EXHIBIT 99.2 - PRO FORMA FINANCIALS ex_252279.htm EX-99.2 285847
5 ex_252278img001.jpg GRAPHIC 2548
  Complete submission text file 0001437749-21-013049.txt   1050508
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-38247 | Film No.: 21949635
SIC: 2834 Pharmaceutical Preparations